Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 14, 2023
Predictive value of health-related quality of life on radiotherapy-related toxicities in patients with head and neck cancerOumar Billa, Franck Bonnetain, Jérôme Chamois, et al.
NPJ Breast Cancer|February 1, 2025
Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclibSylvain Ladoire, Ariane Mamguem Kamga, Loick Galland, et al.
The Journal of Pathology|March 26, 2011
In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survivalSylvain Ladoire, Grégoire Mignot, Sandrine Dabakuyo, et al.
Breast Cancer Research and Treatment|November 23, 2022
Prognosis of local invasive relapses after carcinoma in situ of the breast: a retrospective study from a population-based registrySamia Kada Mohammed, Tienhan Sandrine Dabakuyo Yonli, Isabelle Desmoulins, et al.
Breast (Edinburgh, Scotland)|September 7, 2024
Real-world prevalence, treatment and survival of "high risk" early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registrySylvain Ladoire, Ariane Mamguem Kamga, Loick Galland, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|September 23, 2021
Cécile Bernard, Zeinab Hamidou, Oumar Billa, et al.
JAMA Surgery|February 17, 2021
Five-Year Survival Outcomes of Hybrid Minimally Invasive Esophagectomy in Esophageal Cancer: Results of the MIRO Randomized Clinical TrialFrederiek Nuytens, Tienhan Sandrine Dabakuyo-Yonli, Bernard Meunier, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2012
Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trialsCarine A Bellera, Marina Pulido, Sophie Gourgou, et al.
Annals of Surgery|August 13, 2019
Health-related Quality of Life Following Hybrid Minimally Invasive Versus Open Esophagectomy for Patients With Esophageal Cancer, Analysis of a Multicenter, Open-label, Randomized Phase III Controlled Trial: The MIRO TrialChristophe Mariette, Sheraz Markar, Tienhan Sandrine Dabakuyo-Yonli, et al.
The American Journal of Tropical Medicine and Hygiene|December 18, 2023
A Qualitative Study of the Experience of COVID-19 Patients in Burkina FasoBlahima Konaté, Rachel Médah, Isidore Traoré, et al.
Pageof 8